MONET1-MOtesanib NSCLC Efficacy and Tolerability Study

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
To determine if treatment with AMG 706 (motesanib diphosphate) in combination with paclitaxel and carboplatin improves overall survival compared to treatment with placebo in combination with paclitaxel and carboplatin in subjects with advanced non-squamous NSCLC and in subjects with adenocarcinoma histology (adenocarcinoma subpopulation).
Epistemonikos ID: 9aedef9db02e2aff3982d5494045dc6a3a5b361c
First added on: Mar 14, 2018